Home 2012

February 2012 Vol. 7 No. 2

FDA approves Surfaxin to prevent respiratory distress syndrome in premature infants.
Clinical Topics

FDA approves Surfaxin to prevent respiratory distress syndrome in premature infants.

Sharps Safety Consensus Statement and Call to Action
Cardio-Pulmonary

Sharps Safety Consensus Statement and Call to Action

FDA approves Korlym for hyperglycemia in patients with endogenous Cushing’s syndrome
Clinical Topics

FDA approves Korlym for hyperglycemia in patients with endogenous Cushing’s syndrome

FDA approves first quadrivalent vaccine to prevent seasonal influenza
Clinical Topics

FDA approves first quadrivalent vaccine to prevent seasonal influenza

Public reporting of quality data has not significantly reduced mortality
Clinical Topics

Public reporting of quality data has not significantly reduced mortality

FDA warns of counterfeit Avastin
Clinical Topics

FDA warns of counterfeit Avastin

FDA approves Kalydeco for rare form of cystic fibrosis
Clinical Topics

FDA approves Kalydeco for rare form of cystic fibrosis

Polypectomy lowers colorectal cancer mortality
Clinical Topics

Polypectomy lowers colorectal cancer mortality

Migraine increases risk of depression in women
Clinical Topics

Migraine increases risk of depression in women

Visits to ED for dental problems increase
Clinical Topics

Visits to ED for dental problems increase

Joint Commission awards first certifications for palliative care
Clinical Topics

Joint Commission awards first certifications for palliative care

C. difficile infections at record high
Clinical Topics

C. difficile infections at record high

AHRQ reports results from survey on patient safety culture
Clinical Topics

AHRQ reports results from survey on patient safety culture

123Page 1 of 3

Early Release Articles

Powered by  HCM   www.HealthComMedia.com

© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder